by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Apr 6, 2012 | Saving Money on Prescription Drugs, Skipping medications
Some pharmaceutical industry folks, and their political allies, like to make the point that our nation’s seniors no longer need access to lower-cost foreign medication because they now have new and improved Medicare drug plans. But a new report by IMS indicates that drug costs are having a negative effect on public health, including for our seniors’. Put simply, the data indicates that even with the improvements and savings offered by Part D of Medicare (Medicare’s drug benefit), seniors still struggle to afford the drugs they need.
According to the report, medicine use by 65-year-olds decreased 3.1% — the largest decrease in any age group. As reported in the New York Times, Michael Kleinrock, director of research development at the IMS Institute for Health Informatics, a group that consults for the drug industry, said that seniors appear to be “rationing their care as they struggled to pay rising bills on fixed incomes.” Mr. Kleinrock also said, “We’re reaching a tipping point where patients will actually take that increased cost and use less medicine.” Leigh Purvis, who studies drug prices for the AARP explains that the drugs most often cut are those “where you don’t necessarily develop symptoms when you stop taking them.”
Source: IMS Health, LifeLink, Dec 2011; U.S. Census Bureau
Such cutbacks in drug utilization for needed medication are known to lead to increased emergency room visits and greater social costs. Indeed, according to the IMS data, emergency room visits are up by 7.4%. Other studies, such as one by the Commonwealth Fund, have shown that medication nonadherence (skipping your prescribed medication) has been linked to increased emergency room visits, hospital stays, and nursing home admissions. The new IMS report illustrates this correlation as it finds seniors cutting back on needed medication.
Some improvements to Part D of Medicare have already been implemented and the IMS data shows a $1.8 billion decrease in out-of-pocket spending on prescription medication that is likely due to these improvements. More improvements are on the way as long as the Affordable Care Act is not overturned. However, it’s clear that our seniors continue to suffer negative health consequences because of drug affordability problems.
A recent survey by RxRights.org, a non-profit group advocating for Americans who purchase medication from Canada and other countries, shows that just over half of people who personally import medication through online pharmacies are in Medicare. So even with Part D available to them, they actively seek lower drug prices outside the United States, making it abundantly clear that seniors continue to need the option to personally import prescription medication. It is important that they do so safely, using pharmacies approved by third-party verification programs such as PharmacyChecker.com.
Tagged with: affordable prescriptions, Drug Importation, Drug Prices, IMS Institute for Healthcare Informatics, Medicare Drug Plans, Medicare Part D, seniors
by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Mar 20, 2012 | Drug Prices, Healthcare Reform, Saving Money on Prescription Drugs, Skipping medications
There is a drug affordability crisis in America. As we’ve reported, in 2010 48 million adults did not fill a prescription due to high drug costs. Perhaps surprisingly, in addition to millions of uninsured Americans, many Americans with insurance forgo prescription medication due to cost. Such insured Americans, unable to cover necessary medical costs, including medication, are often referred to as the underinsured. A previous study from 2004 by the American Society of Health-System Pharmacists reveals that 82.1% of those who restricted medication to due costs were actually insured. The picture is clear; underinsurance is a major issue in the battle to afford prescribed medication.
The Affordable Healthcare For America Act will help millions of Americans, including with their drug bills – but it is not a cure-all. It is uncertain how the new regulations will affect drug pricing. With drug price negotiations and cost reducing drug importation measures excluded from the healthcare act, and with millions of insured Americans currently struggling to pay high drug costs, what is to say newly insured people will not struggle to afford or go without prescribed medications?
Throughout the year PharmacyCheckerBlog will be following the research and predictions about drug affordability under the new law. Stay tuned…
Tagged with: affordable prescriptions, Drug Prices, Healthcare Reform
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Mar 7, 2012 | Advocacy, Drug Prices, Medication non-adherence, Skipping medications
Today, the AARP reported that brand name drug prices increased by 41% between 2006-2009, approximately three times the rate of inflation. In the New York Times article announcing the study, AARP refers to the price increases as “relentless”. The media often reports on studies about drug price increases because it’s an issue of great frustration for millions of Americans; and this blog has presented the facts on how tens of millions of Americans skip medication due to cost. But what are the public health ramifications of high drug costs? (more…)
Tagged with: AARP, drug prices out of reach, durg price study
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Mar 22, 2010 | Skipping medications
Last month we reported on the national crisis of high prescription drug prices, showing that at the beginning of the recession 40% of Americans were struggling to afford their prescription drug prices (Harvard School of Public Health). Sadly, new data further highlights this national emergency and shows that the problem is getting worse. Focusing on Americans with insurance, a report by Wolter Kluwer Pharma Solutions found that 14.4% of new prescriptions were not filled in 2009, an increase of 5.5% over 2008. The study attributed the increase to rising co-payments. In fact, 24% more prescriptions were simply abandoned in 2009 than 2008. Prescription abandonment is when a patient does not pick up his or her prescription at the pharmacy. The problem is more acute with brand name drugs than generics.
To stop the increasing tide of Americans skipping their medications due to cost, it is more urgent than ever that increase access to safe and affordable medication. In the short term, healthcare reform will provide limited drug price relief but will not significantly help struggling Americans any time soon. However, low-cost online pharmacies and personal drug importation can play an important role in making sure Americans are taking the medicines they need right now. Canadian and other international online pharmacies, for example, offer drug savings of about 70% on brand name drugs. Legalizing personal drug importation and educating consumers about how to safely order prescription drugs from such pharmacies is the right prescription.
Tagged with: Drug Price S.O.S., Harvard School of Public Health, health reform, Healthcare Reform, prescription abandonment, wolter kluwer
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Feb 9, 2010 | Skipping medications
To launch our new blog, we thought we’d get to the heart of the matter. Prescription drug prices are out of reach for almost half the country. Brand name drugs are, on average, 50% higher in the United States than other countries. In fact, when comparing prescription drug prices online, the savings outside the U.S. are over 70%. That is the main reason Americans have turned to online pharmacies and personal drug importation. (more…)
Tagged with: Drug Importation, Drug Price S.O.S., Drug Prices, Harvard School of Public Health
